Results 161 to 170 of about 1,772 (177)

Attenuated NYCBH Vaccinia Virus Deleted for the E3L Gene Confers Partial Protection Against Lethal Monkeypox Virus Disease in Cynomolgus Macaques [PDF]

open access: yesVaccine, 2011
The New York City Board of Health (NYCBH) vaccinia virus is the currently licensed vaccine for use in the US against smallpox. The vaccine under investigation in this study has been attenuated by deletion of the innate immune evasion gene, E3L, and shown to be protective in homologous virus mouse challenge and heterologous virus mouse and rabbit ...
Bertram L Jacobs
exaly   +3 more sources

The Vaccinia Virus E3L Protein Interacts With SUMO-1 and Ribosomal Protein L23a in a Yeast Two Hybrid Assay

Virus Genes, 2000
We report the results of a two-hybrid study which identified clones from a HeLa cDNA library that interact with the vaccinia virus protein E3L. These clones encode the nuclear protein SUMO-1 (also known as PIC-1, sentrin or GMP-1); the cytoplasmic ribosomal protein L23a; and a small peptide sequence of unknown significance.
Shaun Heaphy
exaly   +4 more sources

Identification of a Conserved Motif That Is Necessary for Binding of the Vaccinia Virus E3L Gene Products to Double-Stranded RNA

Virology, 1993
The E3L gene of vaccinia virus encodes the double-stranded (ds) RNA binding proteins p20 and p25 that exhibit inhibitory activity for the IFN-induced, P1/elF-2 alpha protein kinase. A region in the E3L encoded proteins (residues 156-180) shares a high degree of similarity with several proteins that bind double-helical RNA including the P1/elF-1 alpha ...
H W, Chang, B L, Jacobs
openaire   +2 more sources

Modified Vaccinia Virus Ankara Protein F1L Is a Novel BH3-Domain-Binding Protein and Acts Together With the Early Viral Protein E3L to Block Virus-Associated Apoptosis

open access: yesCell Death and Differentiation, 2006
Infection with viruses often protects the infected cell against external stimuli to apoptosis. Here we explore the balance of apoptosis induction and inhibition for infection with the modified vaccinia virus Ankara (MVA), using two MVA mutants with ...
Gerd Sutter   +2 more
exaly   +2 more sources

Role of the Vaccinia Virus E3L and K3L Gene Products in Rescue of VSV and EMCV from the Effects of IFN-α

Journal of Interferon & Cytokine Research, 1998
Vaccinia virus (VV) has been shown to be relatively resistant to the antiviral effects of interferon-alpha (IFN-alpha) and to rescue replication of IFN-sensitive viruses, such as encephalomyocarditis virus (EMCV) and vesicular stomatitis virus (VSV), from the antiviral effects of IFN.
S T, Shors   +4 more
openaire   +2 more sources

Effect of MSC treatment on LPS-induced inflammation, emphysema and atherosclerosis inE3Lmice

3.3 Mechanisms of Lung Injury and Repair, 2015
Background: COPD patients have an increased risk of cardiovascular diseases (CVD), which may be linked through systemic inflammation triggered by smoke and microbial exposure. Recent studies show the promising antiinflammatory and regenerative effects of mesenchymal stromal cells (MSC).
Padmini Khedoe   +11 more
openaire   +1 more source

PS20 - 92. Inhibition of the central melanocortin system affects VLDL metabolism in E3L and E3L.CETP mice

Nederlands Tijdschrift voor Diabetologie, 2012
The central melanocortin system is known to regulate food intake, adiposity, blood pressure, and glucose metabolism. Recently, it has been reported that the melanocortin system also regulates cholesterol metabolism. Studies in wild-type rats and mice showed increased HDL cholesterol levels upon chronic central infusion with SHU9119, a melanocortin 3/4 ...
Sander Kooijman   +5 more
openaire   +1 more source

How Feasible Is Docking of PROTACs to POI-E3L Complexes? Testing Physics-Based and ML-Based Docking Tools

Journal of Chemical Information and Modeling
Targeted protein degradation (TPD) is an innovative drug discovery approach that leverages small molecules to induce proximity between a protein of interest (POI) and an E3 ubiquitin ligase (E3L) for selective degradation. Among TPD modalities, proteolysis-targeting chimeras (PROTACs) present unique challenges for computational modeling due to their ...
Roberto Jiménez-Boi   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy